PH21601A - Method of lowering lipid levels - Google Patents

Method of lowering lipid levels

Info

Publication number
PH21601A
PH21601A PH31058A PH31058A PH21601A PH 21601 A PH21601 A PH 21601A PH 31058 A PH31058 A PH 31058A PH 31058 A PH31058 A PH 31058A PH 21601 A PH21601 A PH 21601A
Authority
PH
Philippines
Prior art keywords
lipid levels
thioxomethyl
napthalenyl
methylglycine
methoxy
Prior art date
Application number
PH31058A
Other languages
English (en)
Inventor
Kallai-Sanfacon Mary-Ann
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of PH21601A publication Critical patent/PH21601A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
PH31058A 1983-08-01 1984-08-01 Method of lowering lipid levels PH21601A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/518,997 US4492706A (en) 1983-08-01 1983-08-01 Method of lowering lipid levels

Publications (1)

Publication Number Publication Date
PH21601A true PH21601A (en) 1987-12-11

Family

ID=24066357

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31058A PH21601A (en) 1983-08-01 1984-08-01 Method of lowering lipid levels

Country Status (9)

Country Link
US (1) US4492706A (ja)
EP (1) EP0132994B1 (ja)
JP (1) JPS6056920A (ja)
AT (1) ATE34661T1 (ja)
BE (1) BE900277A (ja)
DE (1) DE3428230A1 (ja)
IT (1) IT1206130B (ja)
PH (1) PH21601A (ja)
ZA (1) ZA845723B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0310931A3 (en) * 1987-10-08 1990-10-03 Ethyl Corporation Poultry feed
JPH01263367A (ja) * 1988-04-14 1989-10-19 Kajima Corp ダイビングプール
US4921710A (en) * 1988-07-21 1990-05-01 Iowa State University Research Foundation, Inc. Method of converting cholesterol in food to coprostanol
US5972685A (en) * 1988-07-21 1999-10-26 Iowa State University Research Foundation, Inc. Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration
JP2551951Y2 (ja) * 1990-09-18 1997-10-27 三菱自動車工業株式会社 レーザ焼入処理した内面を有するシリンダ
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
US5674488A (en) * 1994-10-07 1997-10-07 Reich; John J. Method for prevention and treatment of hyperchlolesterolemia by in vivo hydrogenation of cholesterol
US6127367A (en) * 1996-02-29 2000-10-03 Pfizer, Inc. Method of reducing tissue damage associated with non-cardiac ischemia
WO1999034794A1 (en) * 1998-01-12 1999-07-15 Lipogenics, Inc. Methods for treating diabetic dyslipidemia using tocotrienols

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1191156A (en) * 1981-10-15 1985-07-30 Francesco Bellini N-((6-(lower alkoxy)-5-(trifluoromethylthio)-1- naphthalenyl)-thioxomethyl)-n-(lower alkyl)glycines
AU544067B2 (en) * 1981-03-02 1985-05-16 Wyeth-Ayerst Canada Inc. Thioamides and amides. treatment of diabetes
CA1176269A (en) * 1981-03-02 1984-10-16 Kazimir Sestanj N-naphthoylglycine derivatives
US4446150A (en) * 1982-09-21 1984-05-01 Ayerst, Mckenna & Harrison, Inc. Naphthalenylthiazole derivatives

Also Published As

Publication number Publication date
US4492706A (en) 1985-01-08
ATE34661T1 (de) 1988-06-15
IT8422178A0 (it) 1984-08-01
ZA845723B (en) 1986-03-26
IT1206130B (it) 1989-04-14
EP0132994B1 (en) 1988-06-01
JPS6056920A (ja) 1985-04-02
DE3428230A1 (de) 1985-02-21
BE900277A (fr) 1985-02-01
EP0132994A1 (en) 1985-02-13

Similar Documents

Publication Publication Date Title
DE3583799D1 (de) Feste zubereitung mit langsamer freisetzung.
ZA891681B (en) Thiazolidinedione derivatives as hypoglycemic agents
PH21601A (en) Method of lowering lipid levels
IT8024827A0 (it) Impiego dell'alfa-chetoglutarato di piridossina nella profilassi della iperlattacidemia.
DE68911501T2 (de) Analgetische antacide Brausezusammensetzung mit reduziertem Natriumgehalt.
DE3573114D1 (en) 3-(2-aryl-2-oxoethyl)-imidazolium salts as hypoglycemic agents
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
AU562643B2 (en) N-arylpiperazine derivatives
HU9300388D0 (en) New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them
ES8506663A1 (es) Un procedimiento para la preparacion de derivados de ariltiazolidindiona
GR80638B (en) Method for the preparation of 2-tolyl-morpholine derivatives and their therapeutical use
EP0260790A3 (en) Use of pinacidil in the treatment of incontinence
RU1799384C (ru) Способ получени производных цефалоспорина, включающих в заместителе в положении 3 азотсодержащий гетероцикл, или их фармацевтически совместимых солей с щелочными металлами
IT8420738A0 (it) Aminoalchilen-eteri e tioeteri naftalenici e loro impieghi farmaceutici.
JO1229B1 (en) Penicillin derivatives
ES532962A0 (es) Un procedimiento para la preparacion de 5-(2, 3-dihidroxifenoxi)-1h-tetrazol
AU3529184A (en) (2,3-b) thieno pyrrole derivatives
BG101180A (en) Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes
DE3374316D1 (en) Penicillin derivatives
GR79114B (ja)
JPS52122381A (en) 3,4-dihydroxycarbostyryl derivatives and their preparation
JPS5283533A (en) 6-substituted naphtehalene-2-oxyalkylamines
JPS539763A (en) Methylidene-amine derivatives
JPS57206683A (en) Pyrimidone salt, manufacture and medicinal composition containing same
ES523452A0 (es) Procedimiento para la preparacion de n-2-((5-(dimetilamino)-metil-2-furanil-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etendiamina